Keyphrases
Myocardial Infarction
100%
Recurrent Stroke
100%
Stroke Prevention
100%
Vitamins
100%
Prevention Trials
100%
Age Impact
100%
Serum Homocysteine
100%
Homocysteine-lowering Therapy
100%
Vitamin Therapy
75%
B Vitamins
50%
Vascular Risk
50%
High Dose
37%
Homocysteine Levels
37%
Stroke Survivors
37%
Renal Function
25%
Randomized Controlled Trial
25%
Subgroup Analysis
25%
Placebo
12%
Clinical Trials
12%
Comorbidity
12%
Cardiovascular Risk
12%
Glomerular Filtration Rate
12%
Risk Reduction
12%
Cardiovascular Disease
12%
Aging Effect
12%
Older Individuals
12%
Patient Benefit
12%
Clinical Factors
12%
Cardiovascular Mortality
12%
Stroke Risk
12%
Vitamin B12
12%
Demographic Factors
12%
Clinical Trial Design
12%
Secondary Stroke
12%
Secondary Stroke Prevention
12%
Reduced Likelihood
12%
Composite Outcome
12%
Young Individuals
12%
Impact Outcomes
12%
Stroke Outcome
12%
Cardiovascular Risk Reduction
12%
Primary Stroke
12%
Folic Acid Fortification
12%
Medicine and Dentistry
Myocardial Infarction
100%
Apoplexy
100%
Homocysteine
100%
Drug Megadose
18%
Clinical Trial
12%
Kidney Function
12%
Randomized Controlled Trial
12%
Subgroup Analysis
12%
Cardiovascular Risk
12%
Cyanocobalamin
12%
Post-Hoc Analysis
12%
Cardiovascular System
6%
Drug Therapy
6%
Glomerular Filtration Rate
6%
Placebo
6%
Cardiovascular Disease
6%
Risk Reduction
6%
Folic Acid
6%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
100%
Homocysteine
100%
Clinical Trial
16%
Randomized Controlled Trial
16%
Cardiovascular Risk
16%
Vitamin B12
16%
Placebo
8%
Cardiovascular Disease
8%
Comorbidity
8%
Folic Acid
8%